Ligand Pharmaceuticals Incorporated
Cash Flow Statement
| Line Item | FY2009 |
|---|---|
| Operating Activities | |
| Net Income | $-1.9M |
| Depreciation & Amortization | $4.6M |
| Depreciation | — |
| Amortization | — |
| Stock-Based Compensation | $3.4M |
| Net Cash from Operating Activities | $-33.8M |
| Investing Activities | |
| Capital Expenditures | $522.0K |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $24.8M |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $-3.7M |
| Net Change in Cash | $-12.7M |
| Free Cash Flow | $-34.3M |